Key facts
- AgiBot, a Chinese robot maker, is planning to list on the Hong Kong stock exchange.
- The company has hired three sponsors to facilitate its initial public offering.
- A US biotech firm developing infant brain injury therapies is also planning a Hong Kong listing.
Chinese robot maker AgiBot is reportedly seeking to list on the Hong Kong stock exchange, having hired three sponsors to manage the process. This move comes as a US-based biotechnology firm, specializing in therapies for infant brain injuries, also plans a listing in Hong Kong. The details surrounding AgiBot's specific robotic technologies or its financial targets for the IPO were not immediately available.